We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$102B
AUM Growth
-$5.35B
Cap. Flow
-$8.86B
Cap. Flow %
-8.69%
Top 10 Hldgs %
19.26%
Holding
4,322
New
373
Increased
1,162
Reduced
2,180
Closed
377

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$1.18B
2
NLSN
Nielsen Holdings plc
NLSN
+$243M
3
JNPR
Juniper Networks
JNPR
+$212M
4
T icon
AT&T
T
+$196M
5
UBS icon
UBS Group
UBS
+$161M

Sector Composition

Rank Sector Weight
1 Technology 11.05%
2 Financials 10.64%
3 Healthcare 10.15%
4 Consumer Discretionary 7.33%
5 Industrials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCSM icon
3651
NCS Multistage Holdings
NCSM
$116M
$149K ﹤0.01%
515
-55
-10% -$17.5K
NERV icon
3652
Minerva Neurosciences
NERV
$191M
$149K ﹤0.01%
2,244
+476
+27% +$28.9K
MYN icon
3653
BlackRock MuniYield New York Quality Fund
MYN
$376M
$146K ﹤0.01%
12,200
INSY
3654
DELISTED
Insys Therapeutics, Inc.
INSY
$143K ﹤0.01%
19,768
-692
-3% -$4.83K
DS
3655
DELISTED
Drive Shack Inc.
DS
$141K ﹤0.01%
18,260
-6,908
-27% -$41.7K
GSUM
3656
DELISTED
Gridsum Holding Inc.
GSUM
$139K ﹤0.01%
20,002
-27,969
-58% -$185K
AGEN
3657
Agenus
AGEN
$276M
$136K ﹤0.01%
3,039
-767
-20% -$51.7K
PES
3658
DELISTED
Pioneer Energy Services Corp.
PES
$136K ﹤0.01%
23,250
-5,553
-19% -$24.7K
VNRX icon
3659
VolitionRx Ltd
VNRX
$9.31M
$130K ﹤0.01%
3,250
VSTM icon
3660
Verastem
VSTM
$528M
$130K ﹤0.01%
+1,569
New +$96K
URA icon
3661
Global X Uranium ETF
URA
$5.21B
$129K ﹤0.01%
10,000
AUPH icon
3662
Aurinia Pharmaceuticals
AUPH
$1.95B
$128K ﹤0.01%
22,878
-5,422
-19% -$30.2K
LAC
3663
DELISTED
Lithium Americas Corp. Common Shares
LAC
$126K ﹤0.01%
23,424
-15,173
-39% -$82.9K
CSIQ icon
3664
Canadian Solar
CSIQ
$932M
$125K ﹤0.01%
10,235
+229
+2% +$3.44K
ARQL
3665
DELISTED
Arqule Inc
ARQL
$124K ﹤0.01%
+22,483
New +$85.9K
SPNS
3666
DELISTED
Sapiens International
SPNS
$123K ﹤0.01%
12,618
-5,155
-29% -$47.7K
NETI
3667
DELISTED
Eneti Inc.
NETI
$123K ﹤0.01%
1,877
-472
-20% -$32.5K
CASI
3668
DELISTED
CASI Pharmaceuticals
CASI
$122K ﹤0.01%
+1,481
New +$100K
MNOV icon
3669
MediciNova
MNOV
$63.5M
$122K ﹤0.01%
15,317
-21,820
-59% -$226K
VCEL icon
3670
Vericel Corp
VCEL
$2.38B
$120K ﹤0.01%
+12,365
New +$154K
SFS
3671
DELISTED
Smart & Final Stores, Inc.
SFS
$118K ﹤0.01%
21,333
+8,768
+70% +$44.4K
DHT icon
3672
DHT Holdings
DHT
$2.99B
$117K ﹤0.01%
24,982
-9,299
-27% -$36.8K
ORC
3673
Orchid Island Capital
ORC
$1.31B
$114K ﹤0.01%
3,028
-920
-23% -$33.9K
METC icon
3674
Ramaco Resources Class A
METC
$629M
$112K ﹤0.01%
16,640
-12,105
-42% -$86.2K
EMITF
3675
DELISTED
Elbit Imaging Ltd
EMITF
$112K ﹤0.01%
+48,073
New +$116K

Similar funds

Credit Suisse's Q2 2018 Portfolio in Review

As of Q2 2018, Credit Suisse held 4,322 positions worth $102B, down 5% from $107B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Credit Suisse withdrew a net $8.86B in Q2 2018, closing 377 positions and reducing 2,180 holdings. Its most notable exit was Time Warner Inc, an estimated $736M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Credit Suisse opened a new position in Optimum Communications Inc worth $41.9M.

  • Credit Suisse's largest Q2 2018 buy was Optimum Communications Inc: 2,458,067 shares worth $41.9M.
  • Credit Suisse added most to UnitedHealth in Q2 2018, an estimated $1.18B increase.
  • Credit Suisse's biggest Q2 2018 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $733M.
  • Credit Suisse fully exited Time Warner Inc in Q2 2018, selling an estimated $736M.
  • Credit Suisse's ten largest holdings make up 19% of its $102B portfolio in Q2 2018.
  • Credit Suisse opened 373 new positions and closed 377 in Q2 2018.
  • Credit Suisse's portfolio value fell 5% quarter-over-quarter to $102B.

Based on Credit Suisse's 13F filing for Q2 2018, filed 14 Aug 2018.